62 related articles for article (PubMed ID: 10840818)
1. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
[TBL] [Abstract][Full Text] [Related]
2. Breast lymphomas: Clinical and pathological insights from a tertiary cancer care center in India.
Singh N; Hayat S; Kumar S; Chowdhury Z; Dhal I; Patne SC; Kadali K; Mishra BK; Kapoor A; Gupta A; Singh A; Sansar B
Indian J Pathol Microbiol; 2024 May; ():. PubMed ID: 38727411
[TBL] [Abstract][Full Text] [Related]
3. Localized anaplastic lymphoma kinase-positive histiocytosis in a cerebellar hemisphere with long-term treatment: illustrative case.
Kumagai E; Tanaka M; Iwasaki F; Yanagimachi M; Hirokawa D; Goto H; Tanaka Y
J Neurosurg Case Lessons; 2024 May; 7(22):. PubMed ID: 38801782
[TBL] [Abstract][Full Text] [Related]
4. An update in management of noncutaneous T-cell lymphomas.
Hwang YY; Liang RH
Adv Hematol; 2010; 2010():424786. PubMed ID: 21188274
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates.
Sato S; Tamai Y
Clin Case Rep; 2020 Oct; 8(10):2067-2068. PubMed ID: 33088554
[TBL] [Abstract][Full Text] [Related]
6. ALK+ ALCL with erythroblast-like cytology diagnosed in ascites in a patient with history of B-cell lymphomas.
Fang H; Li S
Blood; 2023 Nov; 142(19):1672. PubMed ID: 37944178
[No Abstract] [Full Text] [Related]
7. Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.
Weitzman S; Suryanarayan K; Weinstein HJ
Curr Oncol Rep; 2002 Mar; 4(2):107-13. PubMed ID: 11822982
[TBL] [Abstract][Full Text] [Related]
8. Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.
Fiorani C; Vinci G; Sacchi S; Bonaccorsi G; Artusi T
Clin Lymphoma; 2001 Jun; 2(1):29-37; discussion 38-9. PubMed ID: 11707867
[TBL] [Abstract][Full Text] [Related]
9. [The many faces of anaplastic large cell lymphoma].
Foss HD; Marafioti T; Stein H
Pathologe; 2000 Mar; 21(2):124-36. PubMed ID: 10840818
[TBL] [Abstract][Full Text] [Related]
10. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
12. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
[TBL] [Abstract][Full Text] [Related]
13. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease.
Herbst H; Anagnostopoulos J; Heinze B; Dürkop H; Hummel M; Stein H
Blood; 1995 Sep; 86(5):1694-700. PubMed ID: 7655001
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
